ArticleCureus2025
Betulinic Acid Inhibits Collagen-Induced Platelet Adhesion and Activation Through Inhibition of Spleen Tyrosine Kinase (SYK) Phosphorylation.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Betulinic acid is a pentacyclic triterpenoid and is found in various plant species. Betulinic acid has been shown to exhibit several biological activities, such as antiviral, anticancer, immunomodulatory, anti-inflammatory, antimicrobial, anti-diabetic, anti-parasitic, and anti-HIV properties. Additionally, betulinic acid has shown antiplatelet effects against thrombin receptor activator peptide (TRAP), adenosine diphosphate (ADP), and arachidonic acid (AA)-induced platelet activation and aggregation. However, its effect on collagen-induced platelet activation and signaling pathways is not yet known. Therefore, we investigated the effect of betulinic acid on collagen-induced platelet adhesion and activation. Platelets were isolated from mice and labeled with CD41 PE-Cy7 at 37 °C for one hour and induced with various agonists to determine the platelet activation profile against different platelet agonists. Further, the concentration-dependent effect of betulinic acid (100 µM, 300 µM, 500 µM, or 1 mM) against collagen-induced platelet activation was assessed by flow cytometry. Moreover, platelets were labeled with CD41 PE-Cy7 and phospho-spleen tyrosine kinase (SYK) PE at 37 °C for one hour and incubated with betulinic acid (500 µM) or cytochalasin D (1 µg/mL) for 20 minutes, followed by the addition of collagen (25 µg/mL). Thereafter, samples were analyzed by flow cytometer (BD FACSCanto
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.